Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D/C/F/TAF vs DRV+COBI+FTC/TDF in HIV-1 Naive Adults
NCT01565850Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tenofovir alafenamide in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started Apr 2012; status: completed.
02
Drugs
tenofovir alafenamide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01565850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01565850.